{"status": "ok", "totalResults": 11, "articles": [{"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Clive Cookson", "title": "UK biotech group raises \u00a348mn for Alzheimer's research - Financial Times", "description": "AstronauTx\u2019s financing is step towards helping millions of people suffering from disease", "url": "https://www.ft.com/content/c8cc98a0-ef9e-4b44-a3b2-f18a9ed487f4", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F535fe63d-9dfe-46e5-9ed3-c7be77d51c90.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2023-10-08T04:01:40Z", "content": "A UK biotech company exploring new ways of treating Alzheimers and other neurodegenerative diseases has raised \u00a348mn ($61mn) in its first big funding round.\r\nAlthough AstronauTx does not expect any o\u2026 [+3395 chars]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "SciTechDaily"}, "author": null, "title": "Esketamine Nasal Spray: A Game-Changing Treatment for Clinical Depression - SciTechDaily", "description": "Esketamine has showcased promising results in a major clinical trial, proving more effective than standard treatments for treatment-resistant depression. Treatment-resistant depression (TRD) is a particularly challenging form of major depressive disorder. As \u2026", "url": "https://scitechdaily.com/esketamine-nasal-spray-a-game-changing-treatment-for-clinical-depression/", "urlToImage": "https://scitechdaily.com/images/Esketamine-Nasal-Spray.jpg", "publishedAt": "2023-10-07T14:48:55Z", "content": "Esketamine Nasal Spray. In a pivotal trial, esketamine outperformed standard treatments for resistant depression, with 28% of patients achieving remission in eight weeks, versus 18% using quetiapine.\u2026 [+7732 chars]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}]}